Showing results (101-110 of 177) with videos related to
Sort By:
Pageof 18
Journal of Neurology|December 4, 2025
Novel missense ALDH18A1 variant in a family with autosomal dominant spastic paraplegiaFederica Novarella, Alessandra Tessa, Chiara Criscuolo, et al.The Journal of Liquid Biopsy|January 26, 2026
Cell-free RNA profiling uncovers non-canonical circulating D2 transcript elevation in Bladder Cancer plasmaAnnarita Nappi, Felice Crocetto, Paolo Conforti, et al.Frontiers in Neurology|October 3, 2025
Investigating the contribution of laboratory parameters on plasma neurofilament light chain levels in multiple sclerosisValerio Nicolella, Monica Gelzo, Carmela Polito, et al.Clinical Chemistry and Laboratory Medicine|December 11, 2019
Childhood obesity: an overview of laboratory medicine, exercise and microbiomeOlga Scudiero, Raffaela Pero, Annaluisa Ranieri, et al.Endocrinology|March 10, 2007
Conditional inactivation of the E-cadherin gene in thyroid follicular cells affects gland development but does not impair junction formationGaetano Calì, Mariastella Zannini, Patrizia Rubini, et al.Journal of Personalized Medicine|April 3, 2021
Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder CancerMatteo Ferro, Evelina La Civita, Antonietta Liotti, et al.International Journal of Molecular Sciences|March 11, 2023
Radiogenomics in Renal Cancer Management-Current Evidence and Future ProspectsMatteo Ferro, Gennaro Musi, Michele Marchioni, et al.Research and Reports in Urology|June 26, 2025
Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine TherapiesAlberto Quistini, Francesco Chierigo, Giuseppe Fallara, et al.Expert Review of Molecular Diagnostics|October 28, 2023
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identificationMatteo Ferro, Bernardo Rocco, Martina Maggi, et al.Oncotarget|October 30, 2016
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillanceMatteo Ferro, Giuseppe Lucarelli, Dario Bruzzese, et al.Pageof 18